Don’t miss Scailyte’s CEO, Peter Nestorov, at the Genomics for Health 2024 event, bridging cutting-edge science and leading industry.
Continue readingIntegrating single-cell transcriptomics with Artificial Intelligence reveals pan-cancer biomarkers of brain metastasis
Scailyte’s pan-cancer brain metastasis signature, derived via single-cell RNA sequencing and ScaiVision AI, enables early detection, prognosis, and targeted therapy.
Continue readingTracing Endometriosis: Coupling deeply phenotyped, single-cell based Endometrial Differences and AI for disease pathology and prediction
Scailyte’s single-cell atlas reveals key gene changes in endometriosis, offering new insights into pathophysiology, predictive models, and potential treatment targets.
Continue readingThe Year of the AI Nobel
2024 is being hailed as the “Year of the AI Nobel,” marking a milestone as artificial intelligence (AI) researchers received Nobel Prizes across both Physics and Chemistry.
Continue reading